Ellis Investment Partners, LLC Viatris Inc Transaction History

Ellis Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $237 - $311	28 Added 29.17%	124 $1,000
Q2 2022 Aug 01, 2022	SELL	$9.95 - $12.27 $39 - $49	-4 Reduced 4.0%	96 $1,000
Q1 2022 May 03, 2022	BUY	$9.81 - $15.4 $49 - $77	5 Added 5.26%	100 $1,000
Q4 2021 Feb 01, 2022	SELL	$12.09 - $14.68 $1,946 - $2,363	-161 Reduced 62.89%	95 $1,000
Q3 2021 Oct 21, 2021	BUY	$13.25 - $15.13 $13 - $15	1 Added 0.39%	256 $3,000
Q2 2021 Jul 26, 2021	SELL	$12.97 - $16.15 $1,050 - $1,308	-81 Reduced 24.11%	255 $3,000
Q1 2021 May 03, 2021	BUY	$13.59 - $18.54 $4,566 - $6,229	336 New	336 $5,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.